Introduction:

Recombinant DNA technology Market accounted for US$ 865.7 Billion in 2024 and is estimated to be US$ 2768.9 Billion by 2034 and is anticipated to register a CAGR of 13.60%.

Recombinant DNA technology is a tool in gene therapy which involves combining DNA of two different species and incorporating it into a host in order to manipulate specific genes in an organism’s DNA in a precise and controlled manner. Over the past years, this space has witnessed tremendous achievement in the production of recombinant drugs and therapeutics without the help of human donors. Recombinant DNA technology has been used to develop numerous products, including vaccines, that have substantially improved the quality of human life.

Drivers and Restrains:

Drivers	Restrains
Advancements in genetic engineering	High cost
Expansion of Biopharmaceutical industry	Adverse side effects
Rising research activities

Regional Insights:

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America market is estimated to witness a significantly high revenue share over the forecast period due to rising investment and funding.

• Effective regulatory bodies
• Use of technology

• Asia Pacific market is estimated to witness a fastest revenue share over the forecast period.

• Rising Health Awareness
• Rising R&D investments

Dividing this target market into segments:

Recombinant DNA technology Market is segmented based on Product Type, Component Type, Application, End-user and Region.

Product Type Insight

On the basis of Product Type, the target market is segmented into Medical (Human Protein, Therapeutic Agent, and Vaccine) and Non-medical (Specialty Chemical, Biotech Crops, and Others

Component Type Insight

On the basis of Component Type, the target market is segmented into Expression System (Mammalian, Bacteria, Yeast, Baculovirus/Insect, and Others) and Cloning Vector.

Application Insight

On the basis of Application, the target market is segmented into Agriculture and Pharmaceuticals (Human, Animal, Environment, and Others.

End-user Insight

On the basis of End-user, the target market is segmented into Pharmaceutical Companies, Research Institutes, and Others.

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product Type - Medical (Human Protein, Therapeutic Agent, and Vaccine) and Non-medical (Specialty Chemical, Biotech Crops, and Others By Component Type - Expression System (Mammalian, Bacteria, Yeast, Baculovirus/Insect, and Others) and Cloning Vector. By Application - Agriculture and Pharmaceuticals (Human, Animal, Environment, and Others. By End-user Insight - Pharmaceutical Companies, Research Institutes, and Others.
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.

Key Players:

The key players operating the Recombinant DNA technology Market includes, Pfizer, Inc., F.Hoffmann-La Roche Ltd, Cibus, Ltd., New England Biolabs,Inc., Trofacgen,Inc., GenScript, Corporation, GlaxoSmithKline plc., Novo Nordisk A\S, Monsanto Company, Eli Lily and Company, Horizon Discovery Group PLC, Amgen Inc., and Novartis AG

Recent Development:

             The New Launched Product News,

• In March 2022, VBI Vaccines Inc. launched PreHevbrio (Recombinant Hepatitis B Vaccine) in the United States for the prevention of infection caused by all known subtypes of hepatitis B virus (HBV) in adults age 18 years and older.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Product Type
     • Market Snippet, By Component Type
     • Market Snippet, By Application Type
     • Market Snippet, By End-Users
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Product Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Medical (Human Protein, Therapeutic Agent, and Vaccine)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Non-medical (Specialty Chemical, Biotech Crops, and Others)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Component Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Expression System (Mammalian, Bacteria, Yeast, Baculovirus/Insect, and Others)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cloning Vector
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Agriculture
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Pharmaceuticals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• (Human, Animal, Environment, and Others)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End User , Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• (Pharmaceutical Companies, Research Institutes, and Others)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

1. Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
     • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Component Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Component Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Component Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific

• Latin America
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Component Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Component Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
2. Company Profiles

• fizer, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• F.Hoffmann-La Roche Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Cibus, Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• New England Biolabs,Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Trofacgen,Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• GenScript.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Corporation.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Novo Nordisk A\S
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Monsanto Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Eli Lily and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact